Immunohistochemical Phenotypes of Phyllodes Tumor of the Breast
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background : The aim of the study is to evaluate the difference of immunophenotypes of stromal cells between the pure phyllodes tumor (PT) type and the co-existent type of phyllodes tumor and fibroadenoma, and between benign and malignant PT. Methods : Immunohistochemical staining for actin, CD34, CD10, c-kit, bcl-2, p53 and MIB-1 was performed using tissue microarray blocks that contained 25 cases of pure PT (16 benign tumors, 4, borderline malignant tumors, and 5 malignant tumors) and 6 cases of co-existent type. Results : The expression rates of CD34 and MIB-1 in the pure PT type were significantly higher and the expression rate of actin in the pure PT was significantly lower than that of the co-existent type. However, there were no significant differences in the bcl-2, CD10, and p53 expressions between the pure PT type and the co-existent type, and no c-kit expression was observed in both types. No significant differences in the CD34, actin, bcl-2, CD10, and p53 expressions between the benign and borderline/malignant PT cases were found. However, a significant difference of the MIB-1 expression rate was noted. Conclusions : The stromal cells of the pure PT type are regarded as less mature myofibroblasts, and the CD10 reactivity in some phyllodes tumors suggests a myoepithelial origin. The MIB-1 labeling index would be useful for the grading of phyllodes tumor.
Abstract
Background : The aim of the study is to evaluate the difference of immunophenotypes of stromal cells between the pure phyllodes tumor (PT) type and the co-existent type of phyllodes tumor and fibroadenoma, and between benign and malignant PT. Methods : Immunohistochemical staining for actin, CD34, CD10, c-kit, bcl-2, p53 and MIB-1 was performed using tissue microarray blocks that contained 25 cases of pure PT (16 benign tumors, 4, borderline malignant tumors, and 5 malignant tumors) and 6 cases of co-existent type. Results : The expression rates of CD34 and MIB-1 in the pure PT type were significantly higher and the expression rate of actin in the pure PT was significantly lower than that of the co-existent type. However, there were no significant differences in the bcl-2, CD10, and p53 expressions between the pure PT type and the co-existent type, and no c-kit expression was observed in both types. No significant differences in the CD34, actin, bcl-2, CD10, and p53 expressions between the benign and borderline/malignant PT cases were found. However, a significant difference of the MIB-1 expression rate was noted. Conclusions : The stromal cells of the pure PT type are regarded as less mature myofibroblasts, and the CD10 reactivity in some phyllodes tumors suggests a myoepithelial origin. The MIB-1 labeling index would be useful for the grading of phyllodes tumor.
참고문헌 (17)
- Dacic S, "Immunohistochemical profile of cystosarcoma phyllodes of the breast: a study of 23 cases", Breast J, 8, pp.376~381 (2002)
- Erhan Y, "p53 and Ki-67 expression as prognostic factors in cystosarcoma phyllodes", Breast J, 8, pp.38~44 (2002)
- Kleer CG, "Pathologic, immunohistochemical, and molecular features of benign and malignant phyllodes tumors of the breast", Mod Pathol, 14, pp.185~190 (2001)
- Niezabitowski A, "Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumor of the breast: immunohistochemical and flow cytometric study of 118 cases", Breast Cancer Res Treat, 65, pp.77~85 (2001)
- Kaya R, "Proliferating activity in differential diagnosis of benign phyllodes tumor and cellular fibroadenomas: is it helpful?", Pathol Oncol Res, 7, pp.213~216 (2001)
- Sawyer EJ, "Malignant phyllodes tumours show stromal overexpression of c-myc and c-kit", J Pathol, 200, pp.59~64 (2003)
- Tan PH, "p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study", Mod Pathol, 18, pp.1527~1534 (2005)
- Rosen PP, "Rosen’s breast pathology. 2nd ed", pp.176~194 (2001), Lippincott Williams & Wilkins
- Moore T, "Expression of CD34 and bcl-2 in phyllodes tumours, fibroadenomas and spindle cell lesions of the breast", Histopathology, 38, pp.62~67 (2001)
- Tse GM, "Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours", J Clin Pathol, 58, pp.185~189 (2005)
- Moritani S, "Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections", Mod Pathol, 15, pp.397~405 (2002)
- Tse GM, "Tumour angiogenesis and p53 protein expression in mammary phyllodes tumors", Mod Pathol, 16, pp.1007~1013 (2003)
- Dunne B, "An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast", Hum Pathol, 34, pp.1009~1015 (2003)
- Chen CM, "CD34, CD117, and actin expression in phyllodes tumor of the breast", J Surg Res, 94, pp.84~91 (2000)
- Barwijuk-Machala M, "AgNOR, Ki-67 and PCNA expression in fibroepithelial tumours of the breast in correlation with morphological features", Folia Morphol, 63, pp.133~135 (2004)
- Chan YJ, "Expression of p53 protein and Ki-67 antigen in phyllodes tumor of the breast", J Chin Med Assoc, 67, pp.3~8 (2004)
- Shpitz B, "Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features", J Surg Oncol, 79, pp.86~92 (2002)